Will I Always Face The Threat Of A Peanut-Laden Kiss Of Death?
A reporter with a serious peanut allergy explains what it is like to process news reports that tout new pharmaceutical products that might minimize the danger of accidental exposure.
Drugs
881-900 of 1,318 results
-
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Tainted Drugs
When Medicine Makes Patients Sicker
The Food and Drug Administration is supposed to inspect all factories, foreign and domestic, that produce drugs for the U.S. market. But a KHN review of thousands of FDA documents 鈥 inspection records, recalls, warning letters and lawsuits 鈥 reveals how drugs that are poorly manufactured or contaminated can reach consumers.
-
Medicaid Patients In Puerto Rico Don鈥檛 Get Coverage For Drugs To Cure Hepatitis C
The program that provides health care for about half of the U.S. territory鈥檚 population cannot afford to cover the drugs.
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 Ask Us Anything!
From Medicare dental coverage to drug prices to fetal tissue research, the panelists answer listeners鈥 questions. Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post join KHN鈥檚 Julie Rovner.
-
How Sen. Orrin Hatch Changed America’s Health Care
Utah's Orrin Hatch is leaving the Senate, after 42 years. The Republican led bipartisan efforts to provide health care to more kids and AIDS patients. He also thrived on donations from the drug industry.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 More On That Texas Lawsuit, And The Best And Worst Health Policy Stories Of The Year
The fallout continues from that Texas court decision that ruled Congress鈥 2017 elimination of the tax penalty for failing to have insurance rendered the entire Affordable Care Act unconstitutional. Meanwhile, enrollment for 2019 at healthcare.gov was down, but far less than many predicted. KHN鈥檚 Julie Rovner, along with panelists Joanne Kenen of Politico, Anna Edney of Bloomberg News and Kimberly Leonard of the Washington Examiner, discuss this, plus the best, most overhyped and nerdiest stories of 2018. Also, Rovner interviews GOP strategist and pollster Frank Luntz.
-
Why The U.S. Remains The World’s Most Expensive Market For 鈥楤iologic鈥 Drugs
Biologic drugs, made from living organisms, are big moneymakers partly because they have little competition from 鈥渂iosimilars.鈥 It鈥檚 a very different story in Europe.
-
Health Care Industry 鈥楶ays Tribute鈥 To California鈥檚 Influential Lawmakers
The leaders of California鈥檚 legislative health committees who wield power over state health policy have been showered with money from the health care sector, with drug companies, health plans, hospitals and doctors providing nearly 40 percent of their 2017-18 campaign funds.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Nurse Denied Life Insurance Because She Carries Naloxone
The U.S. surgeon general has called on "bystanders" to be equipped with the opioid reversal drug to save lives. But when a nurse answered that call, her application for life insurance was denied. Why?
-
For The Asking, A Check Is In The Mail To Help Pay For Costly Drugs
It鈥檚 a little-known secret that patients can get thousands of dollars directly from a drugmaker.
-
‘We’re Fighting For Our Lives’: Patients Protest Sky-High Insulin Prices
The price of insulin keeps going up. For people with Type 1 diabetes, high prices can be a life-or-death issue. Now a grass-roots movement is pushing for change.
-
No Cash, No Heart. Transplant Centers Require Proof Of Payment.
The case of a Michigan woman told to fundraise $10,000 for a heart transplant sparked viral outrage, but experts say 鈥渨allet biopsies鈥 are common.
-
Readers And Tweeters Demand Action On Gun Violence, Mental Health Care Options
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
Government Investigation Finds Flaws In the FDA鈥檚 Orphan Drug Program
A probe by the Government Accountability Office cites breakdowns in the Food and Drug Administration program that approves drugs for rare diseases.
By Sarah Jane Tribble and Sydney Lupkin -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 Reading The Tea Leaves In Blue Wave鈥檚 Wake
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Mary Agnes Carey of Kaiser Health News, Margot Sanger-Katz of The New York Times, Alice Ollstein of Politico and Anna Edney of Bloomberg News discuss the impact of House Democratic leadership elections and their impact on health policy; as well as efforts by the Trump administration to address high drug prices and ensure the safety of medical devices. Plus, Julie Rovner interviews KHN鈥檚 Jay Hancock about the latest 鈥淏ill of the Month.鈥
-
Democrats Winning Key Leadership Jobs Have Taken Millions From Pharma
Top House Republican also received more than $1 million from drugmakers since 2007.